Avanos Medical Income Before Tax Over Time
| AVNS Stock | USD 16.18 1.57 8.85% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Avanos Medical Performance and Avanos Medical Correlation. Avanos |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avanos Medical. If investors know Avanos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avanos Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.38) | Earnings Share 0.47 | Revenue Per Share 14.791 | Quarterly Revenue Growth (0.01) | Return On Assets 0.0208 |
The market value of Avanos Medical is measured differently than its book value, which is the value of Avanos that is recorded on the company's balance sheet. Investors also form their own opinion of Avanos Medical's value that differs from its market value or its book value, called intrinsic value, which is Avanos Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avanos Medical's market value can be influenced by many factors that don't directly affect Avanos Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avanos Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avanos Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avanos Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Income Before Tax Analysis
Compare Avanos Medical and related stocks such as Artivion, Anika Therapeutics, and Sight Sciences Income Before Tax Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AORT | (800 K) | 11.5 M | 12.1 M | 23.3 M | 8.7 M | 5.9 M | 18.4 M | 3.6 M | (6.4 M) | 1.6 M | (17.2 M) | (14.8 M) | (15 M) | (21.6 M) | (20.5 M) |
| ANIK | (1.9 M) | 13.8 M | 19.5 M | 32.5 M | 61.5 M | 48.3 M | 50.9 M | 46.2 M | 23.2 M | 36.1 M | (28.6 M) | 2.4 M | (18.7 M) | (85.3 M) | (81.1 M) |
| SGHT | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (25.9 M) | (34.6 M) | (62.8 M) | (86.2 M) | (55.4 M) | (58.2 M) |
| OFIX | 7.5 M | 20.7 M | 82.7 M | (6.5 M) | 12.5 M | 8.5 M | 19 M | 36.4 M | 22.9 M | (27 M) | (368 K) | (13.5 M) | (17.7 M) | (148.7 M) | (141.2 M) |
| AXGN | 700 K | (6.9 M) | (10.2 M) | (14.6 M) | (17.7 M) | (13.4 M) | (14.4 M) | (10.4 M) | (22.4 M) | (29.1 M) | (23.8 M) | (27 M) | (28.9 M) | (21.7 M) | (20.6 M) |
| SRDX | 1.7 M | 16.3 M | 20.4 M | 18.5 M | 19.7 M | 16.9 M | 7 M | (7.5 M) | 7.6 M | (1.5 M) | 6.3 M | (22.5 M) | 2.5 M | (7.5 M) | (7.1 M) |
| FNA | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 5 M | (13 M) | (67.4 M) | (47.6 M) | (45.2 M) |
| GKOS | (22 M) | (22 M) | (22 M) | (14.2 M) | (14 M) | (38.3 M) | 4.6 M | 1000 | (12.4 M) | (50 M) | (132.3 M) | (49.3 M) | (98.4 M) | (133.7 M) | (127 M) |
| KIDS | (9.8 M) | (9.8 M) | (9.8 M) | (9.8 M) | (9.8 M) | (7.9 M) | (6.6 M) | (8.9 M) | (12 M) | (12.7 M) | (33.7 M) | (17.4 M) | (3.7 M) | (21.3 M) | (22.4 M) |
| CNMD | 1.2 M | (2.3 M) | 59.5 M | 50.6 M | 46.7 M | 45.1 M | 19.4 M | 28.7 M | 50.7 M | 31.2 M | 1.6 M | 73.1 M | (70.9 M) | 80.8 M | 84.9 M |
| LIVN | (5.1 M) | 60.4 M | 75.3 M | 79.9 M | 89.3 M | (39.3 M) | (33 M) | 121.1 M | (247.4 M) | (185.7 M) | (344 M) | (124.5 M) | (75.1 M) | (81.2 M) | (77.2 M) |
| ITGR | (2.3 M) | 48.4 M | 6.7 M | 48.8 M | 76.6 M | (15.7 M) | 1.2 M | 21.8 M | 61.1 M | 105.2 M | 86.2 M | 101.1 M | 76 M | 107.3 M | 112.7 M |
| TMCI | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (4.3 M) | (3.7 M) | (20.6 M) | (42.8 M) | (49.5 M) | (47.1 M) |
| ESTA | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (1.6 M) | (22 M) | (34.8 M) | (20.9 M) | (37.5 M) | (38 M) | (39.7 M) | (72.8 M) | (78.6 M) | (74.7 M) |
| NVRO | (18.8 M) | (18.8 M) | (18.8 M) | (25.7 M) | (30.2 M) | (66.3 M) | (30.2 M) | (35.2 M) | (48.4 M) | (102.1 M) | (82.2 M) | (130.8 M) | 4.3 M | (97.9 M) | (93 M) |
Avanos Medical and related stocks such as Artivion, Anika Therapeutics, and Sight Sciences Income Before Tax description
Income Before Tax which can also be referred as pre-tax income is reported on Avanos Medical income statement and is an important metric when analyzing Avanos Medical profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.My Equities
My Current Equities and Potential Positions
| Avanos Medical | AVNS |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Georgia; U.S.A |
| Exchange | New York Stock Exchange |
USD 16.18
Additional Tools for Avanos Stock Analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.